Is N-acetyl cysteine protective against monocrotaline-induced toxicity?

References

• Acharya M, Lau-Cam CA. (2010). Comparison of the protective actions of N-acetylcysteine, hypotaurine and taurine against acetaminophen-induced hepatoxicity in the rat. J Biomed Sci 17:S35
   PubMed Web of Science ®Google Scholar
• Amin KA, Hassan MS, Awad ES, Hashem, KS. (2011). The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline. Int J Nanomedicine 6:143–9
   PubMed Web of Science ®Google Scholar
• Baybutt RC, Rosales C, Brady H, Molteni A. (2002). Dietary fish oil protects against lung and liver inflammation and fibrosis in monocrotaline treated rats. Toxicology 175:1–13
   PubMed Web of Science ®Google Scholar
• Campian ME, Hardziyenka M, Michel MC, Tan HL. (2006). How valid are animal models to evaluate treatments for pulmonary hypertension? Naunyn Schmiedebergs Arch Pharmacol 373:391–400
   PubMed Web of Science ®Google Scholar
• Chen Y, Ji L, Wang H, Wang Z. (2009). Intracellular glutathione plays important roles in pyrrolizidine alkaloids-induced growth inhibition on hepatocytes. Environ Toxicol Pharmacol 28:357–62
   PubMed Web of Science ®Google Scholar
• Clozel M, Hess P, Rey M, et al. (2006). Bosentan, sildenafil and their combination in the monocrotaline model of pulmonary hypertension in rats. Exp Biol Med 231:967–73
   Web of Science ®Google Scholar
• Copple BL, Banes A, Ganey PE, Roth RA. (2002a). Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicol Sci 65:309–18
   PubMed Web of Science ®Google Scholar
• Copple BL, Ganey PE, Roth RA. (2003). Liver inflammation during monocrotaline hepatotoxicity. Toxicology 190:155–69
   PubMed Web of Science ®Google Scholar
• Copple BL, Woolley B, Banes A, et al. (2002b). Anticoagulants prevent monocrotaline-induced hepatic parenchymal cell injury but not endothelial cell injury in the rat. Toxicol Appl Pharmacol 180:186–96
   PubMed Web of Science ®Google Scholar
• Copple BL, Roth RA, Ganey PE. (2006). Anticoagulation and inhibition of nitric oxide synthase influence hepatic hypoxia after monocrotaline exposure. Toxicology 225:128–37
   PubMed Web of Science ®Google Scholar
• Deleve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. (1996). Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 23:589–99
   PubMed Web of Science ®Google Scholar
• Devadasu VR, Wadsworth RM, Ravi Kumar MN. (2012). Tissue localization of nanoparticles is altered due to hypoxia resulting in poor efficacy of curcumin nanoparticles in pulmonary hypertension. Eur J Pharm Biopharm 80:578–84
   PubMed Web of Science ®Google Scholar
• dos Santos AB, Dorta DJ, Pestana CR, et al. (2009). Dehydromonocrotaline induces cyclosporine A-insensitive mitocondrial permeability transition/cytochrome c release. Toxicon 54:16–22
   PubMed Web of Science ®Google Scholar
• IARC. (1972). Monographs on the evaluation of the carcinogenic risk of chemicals to man. Geneva: World Health Organization, International Agency for Research on Cancer
   Google Scholar
• Itoh T, Nagaya N, Fuji T, et al. (2003). A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rates. Am Thorac Soc 169:34–8
   Google Scholar
• Janero DR. (1990). Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9:515–40
   PubMed Web of Science ®Google Scholar
• Jin HF, Du SX, Zhao X, et al. (2008). Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats. Acta Pharmacol Sin 29:1157–66
   PubMed Web of Science ®Google Scholar
• Joseph B, Kumaran V, Berishvili E, et al. (2006). Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning. Liver Biol Pathobiol Hepatol 44:1411–20
   Google Scholar
• Kang KK, Ahn GJ, Sohn YS, Kim WB. (2003). DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension. J Int Med Res 31:517–28
   PubMed Web of Science ®Google Scholar
• Kelly GS. (1998). Clinical applications of N-acetylcysteine. Altern Med Rev 3:114–27
   PubMedGoogle Scholar
• Klaassen CD. (2001). Casarett and Doull's toxicology. The basic science of poisons. 6th ed. New York: McGraw-Hill
   Google Scholar
• Kodama K, Adachi H. (1999). Improvement of mortality by long-term E4010 treatment in monocrotaline induced pulmonary hypertensive rats. J Pharmacol Exp Therap 290:748–52
   PubMed Web of Science ®Google Scholar
• Lachmanova V, Hnilickova O, Povysilova V, et al. (2005). N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia. Life Sci 77:175–82
   PubMed Web of Science ®Google Scholar
• Lame MW, Jones AD, Wilson DW, et al. (2000). Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells. J Biol Chem 275:29091–9
   PubMed Web of Science ®Google Scholar
• Latcham SL. (2005). Effects of treprostinil sodium in a monocrotaline induced rat model of pulmonary hypertension. Master of Science, A Thesis presented to the Faculty of the Graduate School, University of Missouri-Columbia
   Google Scholar
• Levine DJ. (2006). Diagnosis and management of pulmonary arterial hypertension: implications for respiratory care. Respir Care 51:368–81
   PubMed Web of Science ®Google Scholar
• Liu H, Liu ZY, Guan Q. (2007). Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats. Interact Cardiovasc Thorac Surg 6:608–13
   PubMedGoogle Scholar
• Maioli MA, Alves LC, Perandin D, et al. (2011). Cytotoxicity of monocrotaline in isolated rat hepatocytes: Effects of dithiothreitol and fructose. Toxicon 57:1057–64
   PubMed Web of Science ®Google Scholar
• Mansour HH, Hafez HF, Fahmy NM, Hanafi N. (2008). Protective effect of N-acetylcysteine against radiation induced DNA damage and hepatic toxicity in rats. Biochem Pharmacol 75:773–80
   PubMed Web of Science ®Google Scholar
• Mathew R, Gloster ES, Sundararajan T, et al. (1997). Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension. J Appl Physiol 82:1493–8
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Fagan KA, Gebb SA, et al. (2005). Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 171:494–9
   PubMed Web of Science ®Google Scholar
• Ozer J, Ratner M, Shaw M, et al. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology 245:194–205
   PubMed Web of Science ®Google Scholar
• Raza M, Ahmad M, Gado A, Al-Shabanah OA. (2003). A comparison of hepatoprotective activities of aminoguanidine and N-acetylcysteine in rat against the toxic damage induced by azathioprine. Comp Biochem Physiol C Toxicol Pharmacol 134:451–6
   PubMed Web of Science ®Google Scholar
• Requena JR, Fu MX, Ahmed MU, et al. (1996). Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol Dial Transplant 11:48–53
   PubMed Web of Science ®Google Scholar
• Roeder E, Wiedenfeld H. (2011). Pyrrolizidine alkaloids in plants used in the traditional medicine of Madagascar and the Mascarene islands. Pharmazie 66:637–47
   PubMed Web of Science ®Google Scholar
• Ronisa MJ, Butura A, Sampey BP, et al. (2005). Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic Biol Med 39:619–30
   PubMed Web of Science ®Google Scholar
• Schermuly RT, Kreisselmeier KP, Ghofrani HA, et al. (2004). Chronic sildenafil treatment inhibits monocrotaline induced pulmonary hypertension in rats. Am J Respir Crit Care Med 169:39–45
   PubMed Web of Science ®Google Scholar
• Soto-Blanco B, Medeiros RM, Guerra JL, Gorniak SL. (2001). Lack of protective action of cysteine against the fetotoxic effect of monocrotaline. Food Chem Toxicol 39:635–9
   PubMed Web of Science ®Google Scholar
• Srivastava T, Chosdol K. (2007). Clinical enzymology and its applications. New Delhi: Clinical Biochemistry, Department of Biochemistry, All India Institute of Medical Sciences
   Google Scholar
• Tariq M, Morais C, Sobki S, et al. (1999). N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 14:923–9
   PubMed Web of Science ®Google Scholar
• Terneus MV, Brown JM, Carpenter AB, Valentovic MA. (2008). Comparison of S-adenosyl-l-methionine (SAMe) and N-acetylcysteine (NAC) protective effects on hepatic damage when administered after acetaminophen overdose. Toxicology 244:25–34
   PubMed Web of Science ®Google Scholar
• Thapa BR, Walia A. (2007). Liver function tests and their interpretation. Indian J Pediatr 74:663–71
   PubMed Web of Science ®Google Scholar
• Toher CA. (2005). Update on pulmonary hypertension diagnosis, pathophysiology and treatment. The Bulletin 47:45–54
   Google Scholar
• Tran A, Treluyer JM, Rey E, et al. (2001). Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat. Toxicol Appl Pharmacol 170:145–52
   PubMed Web of Science ®Google Scholar
• Tuder RM, Lee SD, Cool CC. (1998). Histopathology of pulmonary hypertension. Chest 114:1–6
   PubMedGoogle Scholar
• Ulicna O, Greksak M, Vancova O, et al. (2003). Hepatoprotective effect of Rooibos Tea (Aspalathus linearis) on CCl4-induced liver damage in rats. Physiol Res 52:461–6
   PubMed Web of Science ®Google Scholar
• Wang X, Kanel GC, Deleve LD. (2000). Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology 31:428–34
   PubMed Web of Science ®Google Scholar
• Wang Y, Jing L, Zhao XM, et al. (2011). Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model. Respir Res 12:26
   PubMed Web of Science ®Google Scholar
• Wanstall JC, O’Donnell SR. (1992). Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br J Pharmacol 105:152–8
   PubMed Web of Science ®Google Scholar
• WHO. (1988). Environ Health Criteria 80: pyrrolizidine alkaloids. Geneva: WHO
   Google Scholar
• Wiedenfield H, Edgar J. (2011). Toxicity of pyrrolizidine alkaloids to humans and ruminants. Phytochem Rev 10:137–51
   Web of Science ®Google Scholar
• Yamashita Y, Fujise N, Imai E, Masunaga H. (2002). Reduction of monocrotaline-induced hepatic injury by deleted variant of hepatocyte growth factor (dHGF) in rats. Liver 22:302–307
   PubMedGoogle Scholar
• Yedjou CG, Rogers C, Brown E, Tchounwou PB. (2008). Differential effect of ascorbic acid and N-acetylcysteine on arsenic trioxide-mediated oxidative stress in human leukemia (HL-60) cells. J Biochem Mol Toxicol 22:85–92
   PubMed Web of Science ®Google Scholar
• Yee SB, Kinser S, Hill DA, et al. (2000). Synergistic hepatotoxicity from coexposure to bacterial endotoxin and the pyrrolizidine alkaloid monocrotaline. Toxicol Appl Pharmacol 166:173–85
   PubMed Web of Science ®Google Scholar
• Yee SB, Ganey PE, Roth RA. (2002). The role of Kupffer cells and TNF-alpha in monocrotaline and bacterial lipopolysaccharide-induced liver injury. Toxicol Sci 71:124–32
   Web of Science ®Google Scholar
• Yousef MI, Omar SA, El-Guendi MI, Abdelmegid LA. (2010). Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem Toxicol 48:3246–61
   PubMed Web of Science ®Google Scholar